Browse 881 autoimmune disorders clinical trials enrolling across the United States and Canada. 117 people applied to autoimmune disorders studies last month. Search by city or state to find one near you.
There are more than 80 autoimmune diseases, from rheumatoid arthritis and psoriasis to lupus and multiple sclerosis, and together they affect a large share of people, most of them women. In each one, the immune system mistakenly attacks the body's own tissues. Treatment has moved from broad immune suppression to medicines that block specific immune signals, and most recently to approaches that aim to reset the immune system entirely.
Mesenchymal Stem Cells for the Treatment of Various Chronic and Acute Conditions
for
Autoimmune Diseases, Cardiovascular Disorders,
Location: Culver City CA
Sponsor: Thomas Advanced Medical LLC
Sex: All
Age: 18+
Code: NCT04684602
Phase 1, Phase 2, Recruiting
Testicular Tissue Cryopreservation for Fertility Preservation
for
Cancer, Autoimmune Disorders
Location: Pittsburgh PA
Sponsor: University of Pittsburgh
Sex: Male
Age: 0+
Code: NCT02972801
Recruiting
Ovarian Tissue Cryopreservation for Fertility Preservation
for
Cancer, Autoimmune Diseases
Location: Pittsburgh PA
Sponsor: University of Pittsburgh
Sex: Female
Age: 0 - 39
Code: NCT05875155
Recruiting
The 1200 Patients Project: Studying the Implementation of Clinical Pharmacogenomic Testing
for
Patients Undergoing Routine Health Care, Heart Diseases,
Location: Chicago IL
Sponsor: University of Chicago
Sex: All
Age: 18+
Code: NCT01280825
Recruiting
Proof of Concept Study Evaluating the Efficacy and Safety of ATH-063 Treatment in Patients With Relapsed/Refractory Moderately to Severely Active Ulcerative Colitis (UC)
for
Ulcerative Colitis, Inflammatory Bowel Diseases,
Location: Miami FL, Tampa FL, Cleveland OH, Roswell GA
Sponsor: Athos Therapeutics Inc
Sex: All
Age: 18 - 70+
Code: NCT07513181
Phase 2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Supporting Weak Immune System During Autoimmune Therapy: Testing Panzyga to Prevent Infections
for
Hypogammaglobulinemia, Autoimmune Conditions,
Location: Irving TX, Mesa AZ, Scottsdale AZ
Sponsor: Octapharma
Sex: All
Age: 18+
Code: NCT07220915
Phase 3, Recruiting
A Study of Healthy Donor CD19-targeted Allogeneic CAR T Cells in Participants With Severe, Refractory Autoimmune Diseases
for
Refractory Autoimmune Diseases
Location: Boston MA, Durham NC
Sponsor: Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
Sex: All
Age: 18+
Code: NCT07115745
Phase 1, Recruiting
Randomized Stepped Wedge Study of Emapalumab in APECED Enteritis
Spermatogonial Stem Cell (SSC) Transplant and Testicular Tissue Grafting
for
Infertility, Male, Cancer, Autoimmune Disorder
Location: Pittsburgh PA
Sponsor: University of Pittsburgh
Sex: Male
Age: 0+
Code: NCT04452305
Recruiting
A Study to Investigate the Safety and Pharmacological Effect of a Single Intravenous Infusion of Belantamab in Male and Female Participants Aged 18 to 75 With Autoimmune Disease
for
Autoimmune Diseases
Location: Medley FL, Peachtree Corners GA
Sponsor: GlaxoSmithKline
Sex: All
Age: 18 - 70+
Code: NCT06413511
Phase 1, Recruiting
Testimonials and Navigation in Rheumatology
for
Rheumatologic Disease, Autoimmune Diseases
Location: Boston MA, Worcester MA, Birmingham AL, Evanston IL
Sponsor: University of Alabama at Birmingham
Sex: All
Age: 18+
Code: NCT06469788
Recruiting
Pilot Trial of Allogeneic Blood or Marrow Transplantation for Primary Immunodeficiencies
for
Primary T-cell Immunodeficiency Disorders,
Location: Bethesda MD, Minneapolis MN
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 4 - 70+
Code: NCT02579967
Phase 2, Recruiting
A Study of Treatment of Inflammation Before Stem Cell Transplant in People With a Primary Immune Regulatory Disorder (PIRD) and/or an Autoinflammatory Condition
for
Primary Immune Regulatory Disorder,
Location: New York NY, Philadelphia PA, Atlanta GA, Milwaukee WI,
Sponsor: Joseph Oved
Sex: All
Age: 0+
Code: NCT05787574
Phase 2, Recruiting
Allogeneic Hematopoietic Stem Cell Transplant for Patients With Inborn Errors of Immunity